Literature DB >> 24627959

Nobiletin restores impaired hippocampal mitochondrial bioenergetics in hypothyroidism through activation of matrix substrate-level phosphorylation.

Natia Jojua, Nino Sharikadze, Elene Zhuravliova, Elnari Zaalishvili, David G Mikeladze.   

Abstract

OBJECTIVE: Evaluation of the effect of citrus flavonoid - nobiletin on the bioenergetics of synaptic and non-synaptic mitochondria in the hippocampus of hypothyroid rats.
METHODS: Male Wistar rats were divided into hypothyroid (methimazole-treated), nobiletin supplemented hypothyroid, thyroxine-treated hypothyroid, and euthyroid (control) groups. Synaptic and non-synaptic (cell) mitochondria were isolated from hippocampus. Oligomycin-sensitive, oligomycin-insensitive, α-ketoglutarate dehydrogenase-dependent synthesis of adenosine triphosphate (ATP), succinate dehydrogenase, and hexokinase activities were determined luminometrically and spectrophotometrically, respectively.
RESULTS: Decreased synthesis of oligomycin-sensitive and oligomycin-insensitive ATP in hypothyroid rat hippocampus was observed in synaptic and non-synaptic mitochondria. Supplementation of hypothyroid rats with nobiletin increases oligomycin-insensitive and α-ketoglutarate-dependent production of ATP in both types of mitochondria. The activity of succinate dehydrogenase in non-synaptic mitochondria and the activities of hexokinase in both types of mitochondria were normalized in nobiletin-treated hypothyroid rats. DISCUSSION: Nobiletin restores reduced mitochondrial metabolism in hypothyroid rat hippocampus through acceleration of matrix substrate-level phosphorylation that may be important for the prevention of hypometabolic complications in neurological disorders.

Entities:  

Keywords:  Bioenergetics; Hippocampus; Hypothyroidism; Mitochondria; Nobiletin

Mesh:

Substances:

Year:  2014        PMID: 24627959     DOI: 10.1179/1476830514Y.0000000120

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  5 in total

1.  Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation.

Authors:  Wen Chai; Ji Zhang; Zhengbing Xiang; Honglian Zhang; Zhujun Mei; Hongbing Nie; Renxu Xu; Ping Zhang
Journal:  Metab Brain Dis       Date:  2022-03-10       Impact factor: 3.584

Review 2.  Nobiletin: Targeting the Circadian Network to Promote Bioenergetics and Healthy Aging.

Authors:  E Mileykovskaya; S-H Yoo; W Dowhan; Z Chen
Journal:  Biochemistry (Mosc)       Date:  2020-12       Impact factor: 2.487

3.  Nobiletin enhances the development and quality of bovine embryos in vitro during two key periods of embryonic genome activation.

Authors:  Karina Cañón-Beltrán; Yulia N Cajas; Serafín Peréz-Cerezales; Claudia L V Leal; Ekaitz Agirregoitia; Alfonso Gutierrez-Adán; Encina M González; Dimitrios Rizos
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 4.  The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro.

Authors:  Hao Huang; Linfu Li; Weimei Shi; Hai Liu; Jianqiong Yang; Xiaoliang Yuan; Longhuo Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-27       Impact factor: 2.629

5.  Nobiletin inhibits cell growth through restraining aerobic glycolysis via PKA-CREB pathway in oral squamous cell carcinoma.

Authors:  Chong-Xiang Lin; Cheng-Wei Tu; Yi-Ke Ma; Peng-Cheng Ye; Xia Shao; Zhao-An Yang; Yi-Ming Fang
Journal:  Food Sci Nutr       Date:  2020-05-21       Impact factor: 2.863

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.